The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 07, 2005
Filed:
Aug. 06, 2004
Toru Kontani, Tsukuba, JP;
Junji Miyata, Tsukuba, JP;
Wataru Hamaguchi, Tsukuba, JP;
Tomoaki Kawano, Tsukuba, JP;
Akio Kamikawa, Tsukuba, JP;
Hiroshi Suzuki, Tsukuba, JP;
Kenji Sudo, Tsukuba, JP;
Toru Kontani, Tsukuba, JP;
Junji Miyata, Tsukuba, JP;
Wataru Hamaguchi, Tsukuba, JP;
Tomoaki Kawano, Tsukuba, JP;
Akio Kamikawa, Tsukuba, JP;
Hiroshi Suzuki, Tsukuba, JP;
Kenji Sudo, Tsukuba, JP;
Yamanouchi Pharmaceutical Co., Ltd., Tokyo, JP;
Rational Drug Design Laboratories, Tokyo, JP;
Abstract
A pharmaceutical drug, particularly a novel compound useful for the prophylaxis or therapeutic treatment of various diseases involving infections with viruses of the Herpesviridae family, specifically various herpesvirus infections such as varicella (chicken pox) via varicella zoster virus, varicella zoster via recurrent infection with latent varicella zoster virus, herpes labialis and herpes encephalitis via HSV-1 and genital herpes via HSV-2 infection. N-{2-[(4-Substituted phenyl)amino]-2-oxoethyl}tetrahydro-2H-thiopyran-4-carboxamide derivative where the phenyl group is substituted at position 4 with a specific five-membered or 6-membered heteroaryl group, has such great anti-virus activity that the oral dosing thereof at a low dose enabled the therapeutic treatment of the diseases.